|
Pharmaceutical Products – Conclusion Of A Non-Exclusive Discount Contract According To Section 130A Paragraph 8 Or 130C Paragraph 1 Sgb V For The Period From July 1St, 2026 To Usually June 30Th, 2028. Active Ingredient Brodalumab; Atc Code L04ac12; Dosage Form All; Potency All; Pack Size All (Excluding Clinical Packs),Active Ingredient Cabotegravir; Atc Code J05aj04; Dosage Form All; Potency All; Pack Size All (Excluding Clinical Packs),Active Ingredient Dolutegravir; Atc Code J05aj03; Dosage Form All; Potency All; Pack Size All (Excluding Clinical Packs),Active Ingredient Dolutegravir And Lamivudine; Atc Code J05ar25; Dosage Form All; Potency All; Pack Size All (Excluding Clinical Packs),Active Ingredient Lamivudine, Abacavir And Dolutegravir; Atc Code J05ar13; Dosage Form All; Potency All; Pack Size All (Excluding Clinical Packs),Active Ingredient Eletriptan; Atc Code N02cc06; Dosage Form All; Potency All; Pack Size All (Excluding Clinical Packs),Active Ingredient Eslicarbazepine; Atc Code N03af04; Dosage Form All; Potency All; Pack Size All (Excluding Clinical Packs),Active Ingredient Everolimus; Atc Code L04ah02; Dosage Form Tab; Potency Up To 1 Mg (≤ 1Mg); Pack Size All (Excluding Clinical Packs),Active Ingredient Fusidic Acid; Atc Code D06ax01; Dosage Form Ointment; Potency All; Pack Size All (Excluding Clinical Packs),Active Ingredient Insulin Glargine - Biosimilar; Atc Code A10ae04; Dosage Form All; Potency All; Pack Size All (Excluding Clinical Packs),Active Ingredient Ipratropium Bromide; Atc Code R03bb01; Dosage Form All; Potency All; Pack Size All (Excluding Clinical Packs),Active Ingredient Lanthanum (Iii) Ion; Atc Code V03ae03; Dosage Form All; Potency All; Pack Size All (Excluding Clinical Packs),Active Ingredient Morphine; Atc Code N02aa01; Dosage Form Tab, Smt; Potency All; Pack Size All (Excluding Clinical Packs),Active Ingredient Sodium Oxybate; Atc Code N07xx04; Dosage Form All; Potency All; Pack Size All (Excluding Clinical Packs),Active Ingredient Norethisterone And Estradiol; Atc Code G03fa01; Dosage Form All; Potency All; Pack Size All (Excluding Clinical Packs),Active Ingredient Propranolol; Atc Code C07aa05; Dosage Form Lse; Potency All; Pack Size All (Excluding Clinical Packs),Active Ingredient Rilpivirine; Atc Code J05ag05; Dosage Form Depot Suspension For Injection (Dis); Potency All; Pack Size All (Excluding Clinical Packs),Active Ingredient Clobetasol; Atc Code D07ad01; Dosage Form Loe; Potency 0.5 Mg; Pack Size N3 (Excluding Clinical Packs),Active Ingredient Cyanocobalamin; Atc Code B03ba01; Dosage Form Fta Uta 0.01 Mg N3; Amp 1 Mg N1 N2; Ilo 1 Mg N1 N2, 3 Mg N1 N2 N3; Tei 0.05 Mg N1; Potency See Dosage Form; Pack Size See Dosage Form (Without Hospital Packs),Active Ingredient Dabigatran Etexilate; Atc Code B01ae07; Dosage Form Gra 15.02 Mg N2, 22.53 Mg N2, 30.05 Mg N2, 37.56 Mg N2, 82.62 Mg N2, 112.67 N2; Hkp 56.33 Mg 10 Pcs, 112.67 Mg 100 Pcs; Potency See Dosage Form; Pack Size See Dosage Form (Without Hospital Packs),Active Ingredient Dasatinib; Atc Code L01ea02; Dosage Form Fta 15.8 Mg N2, 39.5 Mg N2, 55.3 Mg N2, 63.2 Mg N1, 79 Mg N1, 110.6 Mg N1; Potency See Dosage Form; Pack Size See Dosage Form (Without Hospital Packs),Active Ingredient Enalapril; Atc Code C09aa02; Dosage Form Smt 0.76 Mg N2, N3; Tab 7.64 Mg N1, N2, 15.29 Mg N1, N2, 22.93 Mg, N1, N2, N3; 30.57 Mg N1, N2, N3; Potency See Dosage Form; Pack Size See Dosage Form (Without Hospital Packs),Active Ingredient Entacapone; Atc Code N04bx02; Dosage Form Fta; Potency 200 Mg; Pack Size N1, N2, N3 (Excluding Clinical Packs),Active Ingredient Fin
|
